05Mar

FDA In Brief: FDA Encourages Inclusion of Older Adult Patients in Cancer Clinical Trials

admin Mar 05, 2020

The following quote is attributed to Richard Pazdur, M.D., director of the FDA’s Oncology Center of Excellence and acting director of the Office of Oncologic Diseases in the FDA’s Center for Drug Evaluation and Research:
“Enrolling a broad representation of patients in clinical trials is an important tenet of clinical research as it facilitates a better understanding of the drug’s benefits and risks across the patient population likely to take the drug. However, because cancer incidence increases with age, and given the aging U.S. population, it’s particularly important now more than ever to ensure that older adults are also enrolling in cancer clinical trials.

Contact

Qtech Solutions Inc

2250 Boundary Road, Unit # 208
Burnaby, BC - V5M 3Z3,
CANADA

Phone: 604.757.7733
    Mail: qpdc@qtech-solutions.ca